Orson Amiri

  proteanTecs, a global leader in deep data analytics, announced the integration of its lifecycle monitoring solutions into SAPEON's next-gen AI chip. Leveraging proteanTecs' ML-driven applications, SAPEON gains profound insights into chip health and performance, optimizing power efficiency, accelerating time-to-market, and enhancing quality and reliability predictively. Sue Ryu, CEO at SAPEON, emphasizes their commitment to delivering state-of-the-art AI technology with enhanced power-cost efficiency, utilizing proteanTecs to further optimize processor performance and ensure reliability at scale, crucial for large-scale AI tasks in datacenters and the cloud. Sanjay Lall, EVP Worldwide Sales at proteanTecs, expresses privilege in collaborating with companies at the forefront of semiconductor development and shaping the future of AI. ProteanTecs' solutions provide SAPEON with data-driven insights, further setting them apart in delivering unparalleled performance, robustness,...

  Tecnotree, a leader in digital platforms and services for AI, 5G, and cloud-native tech, partners with people+ai to contribute to the Open Cloud Compute (OCC) project, aimed at deploying 10,000 micro data centers in India. This initiative aims to decentralize compute power, enabling faster processing and stronger data sovereignty. Tecnotree's collaboration with OCC seeks to shape India's AI landscape, aligning with telecom standards to create a unified platform for AI, Cloud, and 5G services. The partnership, alongside industry giants like AMD, Oracle, and IBM, not only strengthens India’s compute infrastructure but also fosters global collaboration for AI and Cloud standardization. Prianca Ravichander, Tecnotree CMO, emphasizes their commitment to driving AI and Cloud standardization globally, revolutionizing connectivity for over 90 global telecom providers, with a vision of a digitally inclusive future. Read more - https://www.techdogs.com/tech-news/business-wire/tecnotree...

  Open Systems, a leading provider of SASE solutions, has received prestigious awards from TMC and the Globee Business Awards for their outstanding contributions to the field. Their SASE Experience, offering secure connectivity across cloud and hybrid environments, combines various tools into a comprehensive framework. Stefan Keller, Chief Product Officer, emphasizes the importance of network agility in today's dynamic landscape, acknowledging their team's dedication to delivering reliable, secure, and scalable solutions. Rich Tehrani, CEO of TMC, commends Open Systems for their innovative approach, foreseeing continued excellence. These awards reflect Open Systems' pivotal role in streamlining and securing hybrid environments, advancing global business operations. Additionally, Open Systems' recent recognition as a leader in The Forrester Wave™ underscores their commitment to excellence and innovation in the industry. Through their Service Experience Promise, Open Syst...

  Riverbed, a leader in AI Observability, introduced an advanced AI-powered observability platform alongside new solutions and a unified agent to address IT visibility blind spots in public cloud, Zero Trust, SD-WAN, and remote work environments. With Aternity Mobile, IT can proactively monitor enterprise-owned mobile devices, enhancing frontline productivity. Riverbed IQ 2.0, the latest AIOps service, reduces alert fatigue by leveraging AI-driven correlation and automation of data, aiming to optimize digital experiences and simplify IT management. Dave Donatelli, Riverbed's CEO, emphasized the platform's comprehensive data collection and AI capabilities, essential for improving user experiences. Bob Laliberte from theCUBE Research highlighted the platform's potential to enhance operational efficiency and drive business growth through its open architecture and AI-driven solutions, offering nearly 200 automated responses out of the box. Read More - https://www.techdogs.com/t...

  Stronghold's acquisition of 20022 Labs represents a significant milestone in its journey toward innovative digital payment solutions, solidifying its alignment with the ISO 20022 financial messaging standard. With 20022 Labs renowned for its expertise in data-rich payment processing, this collaboration promises to drive payment system innovation, offering businesses a competitive edge through enhanced operational efficiencies, treasury management, customer experience, and regulatory compliance. Strengthening the implementation of ISO 20022 in StrongholdNET not only boosts interoperability within Stronghold’s ecosystem but also promises both domestic and global connectivity in the digital economy. Tammy Camp, CEO of Stronghold, underscores the strategic importance of this integration, highlighting its role in advancing platforms like StrongholdNET. Founder Mike Sigal echoes this sentiment, expressing excitement for the potential to advance Stronghold's leadership in digital pa...

  Rimsys unveils Rimsys Intel, a community-driven platform offering free access to global regulatory intelligence data, in line with its mission to democratize life-saving medical technologies. Founder and CEO James Gianoutsos underscores Rimsys' commitment to accessibility, enabling medtech teams to make informed market access decisions efficiently. To ensure data accuracy amid evolving regulations, Rimsys collaborates with RAPS Regulatory Affairs Certificate (RAC) holders, offering them opportunities to earn recertification credits while contributing to data quality. This partnership mutually benefits by empowering the medtech community with validated regulatory insights and supporting the professional development of RAC holders. Rimsys Intel aims to level the playing field by providing free access to essential regulatory information, catering to solopreneurs and enterprise-level medtech companies alike. Currently in beta, interested users can join the waitlist for early access, ...

  Lantern Pharma Inc. (NASDAQ: LTRN) partners with Oregon Therapeutics to advance the development of XCE853, a pioneering PDI inhibitor, across various cancer types. Leveraging Lantern's RADR® AI platform, the collaboration aims to identify biomarkers and efficacy signatures, crucial for precision development and patient selection. This strategic alliance seeks to address the complexities associated with PDI inhibitors, offering a promising pathway to enhance cancer treatment strategies. Oregon Therapeutics' CEO, Marc-Henry PITTY, underscores XCE853's preclinical efficacy and the potential for targeted development across multiple cancers. Through comprehensive molecular analysis powered by RADR®, the collaboration intends to uncover new insights into XCE853's therapeutic potential and its application in additional cancer indications. Panna Sharma, CEO of Lantern Pharma, emphasizes RADR®'s role in navigating the complexities of drug development, enabling informed dec...